FindTrial
Sign In

Bioimaging markers for diagnosis of postoperative chemotherapy-related brain damage in patients with breast cancer: based on multimodal magnetic resonance imaging characterization and decoding

Bioimaging markers for diagnosis of postoperative chemotherapy-related brain damage in patients with breast cancer: based on multimodal magnetic resonance imaging characterization and decoding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020282
Enrollment
Unknown
Registered
2018-12-22
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer chemotherapy-related cognitive impairment

Interventions

Breast cancer patient chemotherapy group:Nil
Healthy control subjects group:Nil

Sponsors

the First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female breast cancer patients diagnosed by postoperative pathology

Exclusion criteria

Exclusion criteria: 1) central nervous system infection or trauma; 2) cerebrovascular accident or brain surgery; 3) metal implants, involuntary movement patients; 4) MRI contraindications, such as systemic diseases such as diabetes, hypertension, infectious diseases, heart disease, kidney disease, etc.

Design outcomes

Primary

MeasureTime frame
Cognitive function;—

Countries

China

Contacts

Public ContactZhou Fuqing

the First Affiliated Hospital of Nanchang University

fq.chou@yahoo.com+86 13694881033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026